Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 12, 2025, titled "Alkem launches generic empagliflozin and its combinations in India under the brand name Empanorm .".
Press Release Mar 12 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Alkem Laboratories Ltd. on 6ix
Earlier from Alkem Laboratories
- Press Release Feb 04 2025
- Press Release Oct 10 2024
- Press Release Sep 27 2024
- Press Release Jun 25 2024
- Press Release Mar 27 2024
Later from Alkem Laboratories
- Press Release Mar 13 2025
- Press Release Aug 19 2025
- Press Release Sep 22 2025
- Press Release Nov 03 2025
- Press Release (Revised) Nov 03 2025
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories